{"id":"W4283764710","doi":"10.1111/cen3.12717","title":"Systematic review and network meta‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Clinical and Experimental Neuroimmunology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Fingolimod; Natalizumab; Ofatumumab; Placebo; Internal medicine; Subgroup analysis; Lipoarabinomannan; Relative risk; Confidence interval; Randomized controlled trial; Multiple sclerosis; Meta-analysis; Physical therapy; Disease; Alternative medicine; Rituximab; Tuberculosis; Pathology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03320433,0.003117432,0.01782157,0.01002007,0.0008232421,0.003609429,0.002178757,0.002270542,0.003939044],"category_scores_gemma":[0.06707864,0.001407563,0.04123481,0.00889994,0.0009839578,0.002305204,0.001838185,0.001903241,0.0002930997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003234403,"about_ca_system_score_gemma":0.005570242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007238504,"about_ca_topic_score_gemma":0.01451897,"domain_scores_codex":[0.9609969,0.02397056,0.008373147,0.003070482,0.003037283,0.0005516271],"domain_scores_gemma":[0.9483804,0.03847678,0.007748741,0.001664916,0.003208413,0.0005208496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00174024,0.00002132725,0.003611762,0.2185228,0.7697832,0.00009827954,0.00005417196,0.000538265,0.0001530432,0.0001406618,0.0004289318,0.004907306],"study_design_scores_gemma":[0.0007751947,0.0001322353,0.002625874,0.01181778,0.9831427,0.0000415396,0.00002335284,0.0002578258,0.00008320651,0.0001995971,0.0008824905,0.00001825533],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01118484,0.9836974,0.001394394,0.0005206979,0.0004342934,0.0009888031,0.001192279,0.00004014774,0.0005472293],"genre_scores_gemma":[0.4687036,0.515196,0.006207407,0.002207083,0.0006124358,0.004442294,0.002064539,0.00006360777,0.0005030621],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.03320433,"threshold_uncertainty_score":0.1756034,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1831821084242466,"score_gpt":0.3588947609880768,"score_spread":0.1757126525638301,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}